Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000260892

Medchemexpress LLC Zotizalkib | 2648641-36-3 | 98.0% | C21H20F3N5O3 | 10MG
SDP

Catalog No. 5000260892
Encompass_Preferred

Zotizalkib (TPX-0131) is a potent, CNS-penetrant, orally active inhibitor of anaplastic lymphoma kinase (ALK) designed for research use. It demonstrates low-nanomolar activity against wild-type ALK and a broad spectrum of resistance mutations and has shown antitumor effects in preclinical studies.

  • Potent ALK inhibition (IC50 ≈ 1.4 nM).
  • CNS-penetrant, supporting brain exposure in preclinical models.
  • Active against multiple ALK resistance mutations.
  • High chemical purity (~98.0%).
  • Chemical formula C21H20F3N5O3 and molecular weight 447.41 g/mol.
  • Supplied for research use only; not for human or clinical use.

Catalog No. 50-002-60892 Supplier Medchemexpress LLC Supplier No. HY13927910MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Zotizalkib (TPX-0131) is a potent, CNS-penetrant, orally active inhibitor of anaplastic lymphoma kinase (ALK) designed for research use. It demonstrates low-nanomolar activity against wild-type ALK and a broad spectrum of resistance mutations and has shown antitumor effects in preclinical studies.

  • Potent ALK inhibition (IC50 ≈ 1.4 nM).
  • CNS-penetrant, supporting brain exposure in preclinical models.
  • Active against multiple ALK resistance mutations.
  • High chemical purity (~98.0%).
  • Chemical formula C21H20F3N5O3 and molecular weight 447.41 g/mol.
  • Supplied for research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.